Review



anti opg antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems anti opg antibody
    <t>TNF-α</t> most strongly modulates osteocyte-related gene and protein expression. (A) Dot plots of the relative mRNA levels for Tnfsf11 (RANKL) and Tnfrsf11b <t>(OPG)</t> in MLO-Y4 cells stimulated with TNF-α, IL-6 or IL-17 ( n = 3). (B) Dot plots showing enrichment of the osteocyte marker Sost in osteocyte-enriched bone fraction (OEBFs) vs non-digested bone ( n = 3). (C) Dot plots of Tnfsf11 , Tnfrsf11b , and Sost mRNA in OEBF with or without TNF-α ( n = 3). (D) Representative immunoblot of OPG and Sclerostin in OEBF with or without TNF-α; β-actin serves as the loading control. (E) Dot plots of secreted OPG in conditioned medium from MLO-Y4 cells treated with TNF-α, measured by ELISA ( n = 3). Data in (A-C and E) are individual values with the mean ± SD; * p < .05, ** p < .01, *** p < .001; ns indicates not significant by the 2-sided Student’s t -test.
    Anti Opg Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/Mouse+Osteoprotegerin%2FTNFRSF11B+Antibody/pmc12971003-121-59-62
    Average 93 stars, based on 31 article reviews
    anti opg antibody - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Osteocytes regulate osteoprotegerin expression via the p38-MAPK-CREB pathway in rheumatoid arthritis"

    Article Title: Osteocytes regulate osteoprotegerin expression via the p38-MAPK-CREB pathway in rheumatoid arthritis

    Journal: JBMR Plus

    doi: 10.1093/jbmrpl/ziag023

    TNF-α most strongly modulates osteocyte-related gene and protein expression. (A) Dot plots of the relative mRNA levels for Tnfsf11 (RANKL) and Tnfrsf11b (OPG) in MLO-Y4 cells stimulated with TNF-α, IL-6 or IL-17 ( n = 3). (B) Dot plots showing enrichment of the osteocyte marker Sost in osteocyte-enriched bone fraction (OEBFs) vs non-digested bone ( n = 3). (C) Dot plots of Tnfsf11 , Tnfrsf11b , and Sost mRNA in OEBF with or without TNF-α ( n = 3). (D) Representative immunoblot of OPG and Sclerostin in OEBF with or without TNF-α; β-actin serves as the loading control. (E) Dot plots of secreted OPG in conditioned medium from MLO-Y4 cells treated with TNF-α, measured by ELISA ( n = 3). Data in (A-C and E) are individual values with the mean ± SD; * p < .05, ** p < .01, *** p < .001; ns indicates not significant by the 2-sided Student’s t -test.
    Figure Legend Snippet: TNF-α most strongly modulates osteocyte-related gene and protein expression. (A) Dot plots of the relative mRNA levels for Tnfsf11 (RANKL) and Tnfrsf11b (OPG) in MLO-Y4 cells stimulated with TNF-α, IL-6 or IL-17 ( n = 3). (B) Dot plots showing enrichment of the osteocyte marker Sost in osteocyte-enriched bone fraction (OEBFs) vs non-digested bone ( n = 3). (C) Dot plots of Tnfsf11 , Tnfrsf11b , and Sost mRNA in OEBF with or without TNF-α ( n = 3). (D) Representative immunoblot of OPG and Sclerostin in OEBF with or without TNF-α; β-actin serves as the loading control. (E) Dot plots of secreted OPG in conditioned medium from MLO-Y4 cells treated with TNF-α, measured by ELISA ( n = 3). Data in (A-C and E) are individual values with the mean ± SD; * p < .05, ** p < .01, *** p < .001; ns indicates not significant by the 2-sided Student’s t -test.

    Techniques Used: Expressing, Marker, Western Blot, Control, Enzyme-linked Immunosorbent Assay

    TNF-α-induced changes in Wnt/β-catenin-related transcripts and activation of the p38-MAPK-CREB signaling pathway in osteocytes. (A) Dot plots showing relative mRNA levels of Ctnnb1 (β-catenin), Lef1 , and Axin2 in MLO-Y4 cells treated with or without TNF-α ( n = 3). (B) Representative immunoblotting images showing phosphorylated p38 MAPK (p-p38), total p38, phosphorylated CREB (p-CREB), total CREB, phosphorylated JNK (p-JNK), total JNK, phosphorylated ERK (p-ERK), total ERK, and β-actin in MLO-Y4 cells following TNF-α treatment. Data in (A) are shown as individual values with the mean ± SD and were analyzed by the two-sided Student’s t -test. (C) Representative immunoblot of OPG in TNF-α-stimulated MLO-Y4 cells treated with a p38 inhibitor or a CREB inhibitor. Cells were stimulated with TNF-α in the presence or absence of SB203580 (p38 inhibitor) or 666-15 (CREB inhibitor), and total cell lysates were subjected to immunoblotting for OPG. β-actin serves as the loading control. Numeric values shown beneath each band represent the relative expression levels of OPG/β-actin for the corresponding lane. (D) ChIP-PCR demonstrating enrichment of the OPG promoter in anti-CREB immunoprecipitates from MLO-Y4 cells with or without TNF-α stimulation, with densitometric quantification of the ChIP-PCR bands; input DNA served as the internal control, normal IgG as the negative control, and anti-histone H3 as the positive control.
    Figure Legend Snippet: TNF-α-induced changes in Wnt/β-catenin-related transcripts and activation of the p38-MAPK-CREB signaling pathway in osteocytes. (A) Dot plots showing relative mRNA levels of Ctnnb1 (β-catenin), Lef1 , and Axin2 in MLO-Y4 cells treated with or without TNF-α ( n = 3). (B) Representative immunoblotting images showing phosphorylated p38 MAPK (p-p38), total p38, phosphorylated CREB (p-CREB), total CREB, phosphorylated JNK (p-JNK), total JNK, phosphorylated ERK (p-ERK), total ERK, and β-actin in MLO-Y4 cells following TNF-α treatment. Data in (A) are shown as individual values with the mean ± SD and were analyzed by the two-sided Student’s t -test. (C) Representative immunoblot of OPG in TNF-α-stimulated MLO-Y4 cells treated with a p38 inhibitor or a CREB inhibitor. Cells were stimulated with TNF-α in the presence or absence of SB203580 (p38 inhibitor) or 666-15 (CREB inhibitor), and total cell lysates were subjected to immunoblotting for OPG. β-actin serves as the loading control. Numeric values shown beneath each band represent the relative expression levels of OPG/β-actin for the corresponding lane. (D) ChIP-PCR demonstrating enrichment of the OPG promoter in anti-CREB immunoprecipitates from MLO-Y4 cells with or without TNF-α stimulation, with densitometric quantification of the ChIP-PCR bands; input DNA served as the internal control, normal IgG as the negative control, and anti-histone H3 as the positive control.

    Techniques Used: Activation Assay, Western Blot, Control, Expressing, Negative Control, Positive Control

    TNF-α-stimulated osteocyte-conditioned medium (CM) suppresses osteoclast differentiation partially via OPG. (A) Representative TRAP staining of osteoclasts generated under 5 conditions: (1) RANKL alone without any TNF-α source or osteocyte-CM (MLO-Y4−, TNF-α−); (2) direct TNF-α treatment in the absence of MLO-Y4 conditioned medium (MLO-Y4−, TNF-α+); (3) conditioned medium (CM) from unstimulated MLO-Y4 cells (MLO-Y4+, TNF-α−); (4) CM from TNF-α-stimulated MLO-Y4 cells collected after PBS wash and medium replacement (MLO-Y4+, TNF-α+); and (5) TNF-α-stimulated MLO-Y4 CM pre-incubated with a neutralizing anti-OPG antibody (AF459). Scale bars are 500 μm for low magnification and 200 μm for high magnification. (B) Dot plots of the percentage of spreading TRAP-positive osteoclasts for the conditions shown in (A) ( n = 3). (C) Quantitative RT-PCR analysis of Acp5 mRNA expression in osteoclast cultures under the conditions shown in (A). Acp5 expression levels were normalized to the reference gene ( n = 3). Data in (B and C) are individual values with mean ± SD; ** p < .01, **** p < .0001; ns indicates not significant by the one-way ANOVA with Tukey’s post-hoc test.
    Figure Legend Snippet: TNF-α-stimulated osteocyte-conditioned medium (CM) suppresses osteoclast differentiation partially via OPG. (A) Representative TRAP staining of osteoclasts generated under 5 conditions: (1) RANKL alone without any TNF-α source or osteocyte-CM (MLO-Y4−, TNF-α−); (2) direct TNF-α treatment in the absence of MLO-Y4 conditioned medium (MLO-Y4−, TNF-α+); (3) conditioned medium (CM) from unstimulated MLO-Y4 cells (MLO-Y4+, TNF-α−); (4) CM from TNF-α-stimulated MLO-Y4 cells collected after PBS wash and medium replacement (MLO-Y4+, TNF-α+); and (5) TNF-α-stimulated MLO-Y4 CM pre-incubated with a neutralizing anti-OPG antibody (AF459). Scale bars are 500 μm for low magnification and 200 μm for high magnification. (B) Dot plots of the percentage of spreading TRAP-positive osteoclasts for the conditions shown in (A) ( n = 3). (C) Quantitative RT-PCR analysis of Acp5 mRNA expression in osteoclast cultures under the conditions shown in (A). Acp5 expression levels were normalized to the reference gene ( n = 3). Data in (B and C) are individual values with mean ± SD; ** p < .01, **** p < .0001; ns indicates not significant by the one-way ANOVA with Tukey’s post-hoc test.

    Techniques Used: Staining, Generated, Incubation, Quantitative RT-PCR, Expressing

    Related Articles

    other:

    Article Title: Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer.
    Article Snippet: Bufalin is a natural anti-inflammatory small molecule.. Given the close relationship between inflammation and cancer, many scholars have studied the effect of bufalin on cancer in vitro, but in vivo research is still lacking.. A murine bone cancer model was used in this study.

    Cell-Signaling:

    Article Title: Metamizole does not affect fracture healing in a murine ischemia model
    Article Snippet: .. After saving the whole protein fraction, proteins were separated and transferred to membranes by standard protocols and probed using anti-Cyr61 (AF4055; R&D Systems, Minneapolis, United States), anti-CD31 (77,699; Cell Signaling Technology Europe, Frankfurt, Germany), anti-OPG (MAB4591; R&D Systems), anti-RANKL (ab62516; Abcam, Cambridge, United Kingdom), anti-RUNX2 (EPR22858-106; Abcam) and anti-PCNA (HRP-60097; Proteintech, Planegg-Martinsried, Germany) antibodies. ..

    Article Title: Catalpol attenuates postmenopausal osteoporosis by activating SIRT1-mediated P53 deacetylation and inhibiting CASPASE-3-driven osteoblast apoptosis.
    Article Snippet: EX527, a selective SIRT1 inhibitor (Cayman Chemical, Catalog Number 10008072; Molecular Weight 380.4), was reconstituted in DMSO at a concentration of 10 mM and stored at − 20 ◦C. .. The primary antibodies utilized in this study included antiSIRT1 (Abcam, ab110304), anti-acetyl-P53 (Lys382; Cell Signaling Technology, #2570), anti-P53 (Proteintech, 10442–1-AP), anti-cleaved CASPASE-3 (Cell Signaling Technology, #9664), anti-BCL-2 (Abcam, ab32124), anti-BAX (R&D Systems, AF0120), anti-Sp7 (Abcam, ab209484), and anti-OPG (R&D Systems, MAB805), NF-κB (CST #8242, D14E12), acetyl-NF-κB (Lys310; CST #3045), phospho-IκBα (Ser32/36; Abcam ab133462), FOXO3a (CST #12829), acetyl-FOXO3a (Lys271, Affinity Biosciences, AF3771, RRID: AB_2847085), SOD2 (Abcam ab13533, clone 5G11), AMPKα (CST #2532), phospho-AMPKα (Thr172; CST #2535), phospho-ACC (Ser79; CST #3661), and GAPDH (Proteintech 60,004–1-Ig). .. Unless otherwise specified, working dilutions were WB 1:1000 and IHC 1:300; secondaries were HRP-conjugated antirabbit (CST #7074) or anti-mouse (CST #7076).

    Western Blot:

    Article Title: Rapamycin rejuvenates oral health in aging mice
    Article Snippet: Antibody , anti-RANKL (Mouse monoclonal) , Santa Cruz Biotechnology , Cat#: sc377079 , WB (1:1000). .. Antibody , anti-OPG (Goat polyclonal) , R and D Systems , AF459 , WB (1:1000). .. Antibody , anti-IgGκ (Mouse monoclonal) , Santa Cruz Biotechnology , Cat#: sc516102 , WB (1:10000).

    Incubation:

    Article Title: Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor ?B ligand (RANKL) in human breast tumours
    Article Snippet: The sections were then microwaved for 10 minutes in 0.1M Tris/HCl at full power, washed in phosphate buffered saline and blocked with casein (Vector Laboratories Ltd, Peterborough, UK) for 30 minutes. .. The slides were incubated with either mouse monoclonal anti‐OPG (MAB 8051; R&D Systems, Abingdon, Oxford, UK; 1/250 dilution), mouse monoclonal anti‐TRAIL (MAB 687; R&D Systems; 1/100 dilution), or goat polyclonal anti‐RANKL (SC‐7627; Santa Cruz Technology, Santa Cruz, California, USA; 1/100 dilution) for one hour, washed, and incubated for 30 minutes with antimouse/goat biotin conjugated secondary antibody (30 μl/2 ml of casein solution diluted 1/50; Vector Laboratories Ltd). .. Slides were washed and developed using the ABC Elite kit (Vector Laboratories Ltd), followed by diaminobenzidine and a 20 second counterstain with haematoxylin.

    Staining:

    Article Title: Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.
    Article Snippet: .. After thawing for 20 min at room temperature, sections were stained with anti-OPG (MAB 805, R&D Systems, Minneapolis, USA) and anti-RANKL (sc-9073, Santa Cruz Biotechnology, Santa Cruz, USA). .. A standard three-stage immunoperoxidase method was used for each antibody (Vector Laboratories, Lumigen Inc., SouthWeld, USA), and was followed by counterstaining with haematoxylin.

    Enzyme-linked Immunosorbent Assay:




    Similar Products

    94
    ABclonal Biotechnology opg
    High Calcium and Pro-inflammatory Cytokines Increased the Levels of Osteogenesis-Related Proteins in HK-2 Cells. Western blot analysis of <t>ALP,</t> <t>OPN,</t> and <t>OPG</t> in HK-2 cells treated with CaCl 2 (A) TNF-α (B) IL-1β (C) TGF-β1 (D) or BMP-2 (E) for 6 h. The quantitative results showed the fold change of the protein expression compared to the control group. β-actin or tubulin served as the loading control. Data are presented as individual data points (scatter plot) with the mean ± SEM; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 versus the control group (One-way ANOVA).
    Opg, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/TNFRSF11B+Rabbit+pAb/pmc13365047-77-9-25
    Average 94 stars, based on 1 article reviews
    opg - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology opg
    High Calcium and Pro-inflammatory Cytokines Increased the Levels of Osteogenesis-Related Proteins in HK-2 Cells. Western blot analysis of <t>ALP,</t> <t>OPN,</t> and <t>OPG</t> in HK-2 cells treated with CaCl 2 (A) TNF-α (B) IL-1β (C) TGF-β1 (D) or BMP-2 (E) for 6 h. The quantitative results showed the fold change of the protein expression compared to the control group. β-actin or tubulin served as the loading control. Data are presented as individual data points (scatter plot) with the mean ± SEM; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 versus the control group (One-way ANOVA).
    Opg, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/OPG+Antibody/pm40783844-91-4-12
    Average 94 stars, based on 1 article reviews
    opg - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    R&D Systems anti opg antibody
    <t>TNF-α</t> most strongly modulates osteocyte-related gene and protein expression. (A) Dot plots of the relative mRNA levels for Tnfsf11 (RANKL) and Tnfrsf11b <t>(OPG)</t> in MLO-Y4 cells stimulated with TNF-α, IL-6 or IL-17 ( n = 3). (B) Dot plots showing enrichment of the osteocyte marker Sost in osteocyte-enriched bone fraction (OEBFs) vs non-digested bone ( n = 3). (C) Dot plots of Tnfsf11 , Tnfrsf11b , and Sost mRNA in OEBF with or without TNF-α ( n = 3). (D) Representative immunoblot of OPG and Sclerostin in OEBF with or without TNF-α; β-actin serves as the loading control. (E) Dot plots of secreted OPG in conditioned medium from MLO-Y4 cells treated with TNF-α, measured by ELISA ( n = 3). Data in (A-C and E) are individual values with the mean ± SD; * p < .05, ** p < .01, *** p < .001; ns indicates not significant by the 2-sided Student’s t -test.
    Anti Opg Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/Mouse+Osteoprotegerin%2FTNFRSF11B+Antibody/pmc12971003-121-59-62
    Average 93 stars, based on 1 article reviews
    anti opg antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    86
    Huabio Inc mouse anti opg primary antibody
    CIHH <t>downregulates</t> <t>RANKL</t> expression and increases the <t>OPG/RANKL</t> ratio in delayed replanted teeth. A Immunohistochemistry staining showing OPG expression in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. Scale bar: 100 μm. B Immunohistochemistry staining showing RANKL expression in the root and periapical tissue of the NN and CIHH groups. Scale bar: 100 μm. C - D Representative Western blot bands ( C ) and quantitative analysis ( D ) showing OPG and RANKL protein expressions in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. D dentin; P: periodontal ligament; B: bone
    Mouse Anti Opg Primary Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/actin+anti+%CE%B2/pmc13112843-92-11-16
    Average 86 stars, based on 1 article reviews
    mouse anti opg primary antibody - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Huabio Inc mouse anti opg antibody
    CIHH <t>downregulates</t> <t>RANKL</t> expression and increases the <t>OPG/RANKL</t> ratio in delayed replanted teeth. A Immunohistochemistry staining showing OPG expression in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. Scale bar: 100 μm. B Immunohistochemistry staining showing RANKL expression in the root and periapical tissue of the NN and CIHH groups. Scale bar: 100 μm. C - D Representative Western blot bands ( C ) and quantitative analysis ( D ) showing OPG and RANKL protein expressions in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. D dentin; P: periodontal ligament; B: bone
    Mouse Anti Opg Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/actin+anti+%CE%B2/pmc13112843-70-13-17
    Average 86 stars, based on 1 article reviews
    mouse anti opg antibody - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Affinity Biosciences antibodies against opg
    Comparison of mRNA expression levels of TLR4, <t>RANK,</t> <t>RANKL,</t> and <t>OPG</t> in lung tissues of mice in each group. The mRNA levels were detected with real‐time quantitative PCR. (A) Level of RANKL mRNA. (B) Level of OPG mRNA. (C) Level of RANK mRNA. (D) Level of TLR4 mRNA. *** p < 0.001, **** p < 0.0001.
    Antibodies Against Opg, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+opg/anti+osteoprotegerin/pmc12964313-90-5-10
    Average 86 stars, based on 1 article reviews
    antibodies against opg - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    High Calcium and Pro-inflammatory Cytokines Increased the Levels of Osteogenesis-Related Proteins in HK-2 Cells. Western blot analysis of ALP, OPN, and OPG in HK-2 cells treated with CaCl 2 (A) TNF-α (B) IL-1β (C) TGF-β1 (D) or BMP-2 (E) for 6 h. The quantitative results showed the fold change of the protein expression compared to the control group. β-actin or tubulin served as the loading control. Data are presented as individual data points (scatter plot) with the mean ± SEM; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 versus the control group (One-way ANOVA).

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Inflammation-induced osteogenic signaling promotes calcium phosphate crystal formation in kidneys via MAPK, NF-κB, and smad pathways

    doi: 10.3389/fcell.2026.1831072

    Figure Lengend Snippet: High Calcium and Pro-inflammatory Cytokines Increased the Levels of Osteogenesis-Related Proteins in HK-2 Cells. Western blot analysis of ALP, OPN, and OPG in HK-2 cells treated with CaCl 2 (A) TNF-α (B) IL-1β (C) TGF-β1 (D) or BMP-2 (E) for 6 h. The quantitative results showed the fold change of the protein expression compared to the control group. β-actin or tubulin served as the loading control. Data are presented as individual data points (scatter plot) with the mean ± SEM; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 versus the control group (One-way ANOVA).

    Article Snippet: Antibodies for IHC such as OPN (A1499), ALP (A0514), OPG (A2100), Runx2 (A2851), TNF-α (A11534), IL-1β (A11534), TGF-β1 (A16640), and BMP-2 (A0231) were purchased from ABclonal.

    Techniques: Western Blot, Expressing, Control

    Pro-inflammatory Cytokines Upregulated Osteogenesis-related Proteins via the MAPK/NF-κB and Smad Signaling Pathway. HK-2 cells were pretreated with 10 µM ERK inhibitor (U0126), JNK inhibitor (SP600125), p38 inhibitor (SB203580), or NF-κB inhibitor (BAY 11–7,082) for 2 h, and then treated with 20 ng/mL TNF-α (A) or IL-1β (B) for 72 h (C) HK-2 cells were pretreated with 5 µM Smad2/3 inhibitor (SB-525334) for 2 h and then treated with 200 ng/mL TGF-β1 for 72 h (D) HK-2 cells were pretreated with 10 µM Smad1/5/8 inhibitor (LDN-193189) for 2 h and then treated with 100 ng/mL BMP-2 for 72 h. The expression of osteoblast markers (ALP, OPN, and OPG) was examined by Western blotting. The quantitative results showed the fold change of the protein expression compared to the control group. GAPDH served as the loading control. Data are presented as individual data points (scatter plot) with the mean ± SEM; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 versus the control group; # P < 0.05, ## P < 0.01, ### P < 0.001 versus cytokine group (One-way ANOVA).

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Inflammation-induced osteogenic signaling promotes calcium phosphate crystal formation in kidneys via MAPK, NF-κB, and smad pathways

    doi: 10.3389/fcell.2026.1831072

    Figure Lengend Snippet: Pro-inflammatory Cytokines Upregulated Osteogenesis-related Proteins via the MAPK/NF-κB and Smad Signaling Pathway. HK-2 cells were pretreated with 10 µM ERK inhibitor (U0126), JNK inhibitor (SP600125), p38 inhibitor (SB203580), or NF-κB inhibitor (BAY 11–7,082) for 2 h, and then treated with 20 ng/mL TNF-α (A) or IL-1β (B) for 72 h (C) HK-2 cells were pretreated with 5 µM Smad2/3 inhibitor (SB-525334) for 2 h and then treated with 200 ng/mL TGF-β1 for 72 h (D) HK-2 cells were pretreated with 10 µM Smad1/5/8 inhibitor (LDN-193189) for 2 h and then treated with 100 ng/mL BMP-2 for 72 h. The expression of osteoblast markers (ALP, OPN, and OPG) was examined by Western blotting. The quantitative results showed the fold change of the protein expression compared to the control group. GAPDH served as the loading control. Data are presented as individual data points (scatter plot) with the mean ± SEM; n = 3; * P < 0.05, ** P < 0.01, *** P < 0.001 versus the control group; # P < 0.05, ## P < 0.01, ### P < 0.001 versus cytokine group (One-way ANOVA).

    Article Snippet: Antibodies for IHC such as OPN (A1499), ALP (A0514), OPG (A2100), Runx2 (A2851), TNF-α (A11534), IL-1β (A11534), TGF-β1 (A16640), and BMP-2 (A0231) were purchased from ABclonal.

    Techniques: Expressing, Western Blot, Control

    Osteogenesis-related Proteins Directly Regulate Crystal Nucleation, Growth, and Aggregation. (A) CaP crystallization in the presence of OPG, ALP, or OPN was quantified by alizarin red staining. Alizarin red was extracted from the stained crystal and the absorbance was read at 405 nm. The quantitative results showed the fold change of the absorbance compared to the control group. (B) CaP crystals were incubated with OPG, ALP, or OPN for 60 min, the change in the crystal size indicated the crystal growth. The quantitative results indicated the fold change in crystal growth of the experimental group compared to that of the control group. (C) CaP crystals were stirred with ALP, OPN or OPG for 60 min, the number and area of the aggregates were counted. The average area per aggregate was calculated by the formula: The total area of the aggregates in each field/the number of the aggregates in each field. The quantitative results showed the fold change to the control group. Data are mean ± SEM; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 versus the control group (one-way ANOVA, n = 3).

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Inflammation-induced osteogenic signaling promotes calcium phosphate crystal formation in kidneys via MAPK, NF-κB, and smad pathways

    doi: 10.3389/fcell.2026.1831072

    Figure Lengend Snippet: Osteogenesis-related Proteins Directly Regulate Crystal Nucleation, Growth, and Aggregation. (A) CaP crystallization in the presence of OPG, ALP, or OPN was quantified by alizarin red staining. Alizarin red was extracted from the stained crystal and the absorbance was read at 405 nm. The quantitative results showed the fold change of the absorbance compared to the control group. (B) CaP crystals were incubated with OPG, ALP, or OPN for 60 min, the change in the crystal size indicated the crystal growth. The quantitative results indicated the fold change in crystal growth of the experimental group compared to that of the control group. (C) CaP crystals were stirred with ALP, OPN or OPG for 60 min, the number and area of the aggregates were counted. The average area per aggregate was calculated by the formula: The total area of the aggregates in each field/the number of the aggregates in each field. The quantitative results showed the fold change to the control group. Data are mean ± SEM; * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 versus the control group (one-way ANOVA, n = 3).

    Article Snippet: Antibodies for IHC such as OPN (A1499), ALP (A0514), OPG (A2100), Runx2 (A2851), TNF-α (A11534), IL-1β (A11534), TGF-β1 (A16640), and BMP-2 (A0231) were purchased from ABclonal.

    Techniques: Crystallization Assay, Staining, Control, Incubation

    Representative Immunohistochemical Staining of Inflammatory Cytokines and Osteoblast Markers in the Kidneys of Rats Fed a High-Calcium Diet. Representative images of TNF-α, IL-1β, TGF-β1, BMP-2 (inflammatory cytokines) and OPN, OPG, ALP, Runx2 (osteogenesis-related proteins) in kidney tissues from each experimental group are shown (400×). IHC staining was performed to visualize the spatial distribution of target proteins within renal tissue. Scale bar, 20 µm.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Inflammation-induced osteogenic signaling promotes calcium phosphate crystal formation in kidneys via MAPK, NF-κB, and smad pathways

    doi: 10.3389/fcell.2026.1831072

    Figure Lengend Snippet: Representative Immunohistochemical Staining of Inflammatory Cytokines and Osteoblast Markers in the Kidneys of Rats Fed a High-Calcium Diet. Representative images of TNF-α, IL-1β, TGF-β1, BMP-2 (inflammatory cytokines) and OPN, OPG, ALP, Runx2 (osteogenesis-related proteins) in kidney tissues from each experimental group are shown (400×). IHC staining was performed to visualize the spatial distribution of target proteins within renal tissue. Scale bar, 20 µm.

    Article Snippet: Antibodies for IHC such as OPN (A1499), ALP (A0514), OPG (A2100), Runx2 (A2851), TNF-α (A11534), IL-1β (A11534), TGF-β1 (A16640), and BMP-2 (A0231) were purchased from ABclonal.

    Techniques: Immunohistochemical staining, Staining, Immunohistochemistry

    Hypothesized Model of Randall’s Plaque Formation. a, In a high-calcium renal environment, activated macrophages and inflammasomes release pro-inflammatory cytokines, activating signaling pathways such as MAPK, NF-κB, and Smad in renal tubular cells. b, These signaling pathways upregulate proteins involved in osteogenesis, such as Runx2, ALP, OPG, and OPN, and result in an osteogenic transition. c, Calcium-enriched and osteogenesis-related protein-enriched vesicles are released from the basal side of tubule epithelial cells. Osteogenesis-related proteins directly promote the nucleation, growth and aggregation of CaP crystals in these vesicles. d, CaP aggregates-enriched vesicles move to the renal interstitium, calcifying the interstitial collagen, and eventually leading to the formation of Randall’s plaque in the renal papillae. This figure was created by BioRender.com .

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Inflammation-induced osteogenic signaling promotes calcium phosphate crystal formation in kidneys via MAPK, NF-κB, and smad pathways

    doi: 10.3389/fcell.2026.1831072

    Figure Lengend Snippet: Hypothesized Model of Randall’s Plaque Formation. a, In a high-calcium renal environment, activated macrophages and inflammasomes release pro-inflammatory cytokines, activating signaling pathways such as MAPK, NF-κB, and Smad in renal tubular cells. b, These signaling pathways upregulate proteins involved in osteogenesis, such as Runx2, ALP, OPG, and OPN, and result in an osteogenic transition. c, Calcium-enriched and osteogenesis-related protein-enriched vesicles are released from the basal side of tubule epithelial cells. Osteogenesis-related proteins directly promote the nucleation, growth and aggregation of CaP crystals in these vesicles. d, CaP aggregates-enriched vesicles move to the renal interstitium, calcifying the interstitial collagen, and eventually leading to the formation of Randall’s plaque in the renal papillae. This figure was created by BioRender.com .

    Article Snippet: Antibodies for IHC such as OPN (A1499), ALP (A0514), OPG (A2100), Runx2 (A2851), TNF-α (A11534), IL-1β (A11534), TGF-β1 (A16640), and BMP-2 (A0231) were purchased from ABclonal.

    Techniques: Protein-Protein interactions

    TNF-α most strongly modulates osteocyte-related gene and protein expression. (A) Dot plots of the relative mRNA levels for Tnfsf11 (RANKL) and Tnfrsf11b (OPG) in MLO-Y4 cells stimulated with TNF-α, IL-6 or IL-17 ( n = 3). (B) Dot plots showing enrichment of the osteocyte marker Sost in osteocyte-enriched bone fraction (OEBFs) vs non-digested bone ( n = 3). (C) Dot plots of Tnfsf11 , Tnfrsf11b , and Sost mRNA in OEBF with or without TNF-α ( n = 3). (D) Representative immunoblot of OPG and Sclerostin in OEBF with or without TNF-α; β-actin serves as the loading control. (E) Dot plots of secreted OPG in conditioned medium from MLO-Y4 cells treated with TNF-α, measured by ELISA ( n = 3). Data in (A-C and E) are individual values with the mean ± SD; * p < .05, ** p < .01, *** p < .001; ns indicates not significant by the 2-sided Student’s t -test.

    Journal: JBMR Plus

    Article Title: Osteocytes regulate osteoprotegerin expression via the p38-MAPK-CREB pathway in rheumatoid arthritis

    doi: 10.1093/jbmrpl/ziag023

    Figure Lengend Snippet: TNF-α most strongly modulates osteocyte-related gene and protein expression. (A) Dot plots of the relative mRNA levels for Tnfsf11 (RANKL) and Tnfrsf11b (OPG) in MLO-Y4 cells stimulated with TNF-α, IL-6 or IL-17 ( n = 3). (B) Dot plots showing enrichment of the osteocyte marker Sost in osteocyte-enriched bone fraction (OEBFs) vs non-digested bone ( n = 3). (C) Dot plots of Tnfsf11 , Tnfrsf11b , and Sost mRNA in OEBF with or without TNF-α ( n = 3). (D) Representative immunoblot of OPG and Sclerostin in OEBF with or without TNF-α; β-actin serves as the loading control. (E) Dot plots of secreted OPG in conditioned medium from MLO-Y4 cells treated with TNF-α, measured by ELISA ( n = 3). Data in (A-C and E) are individual values with the mean ± SD; * p < .05, ** p < .01, *** p < .001; ns indicates not significant by the 2-sided Student’s t -test.

    Article Snippet: For osteoclast differentiation assays, the following 5 conditions were compared (all containing 100 ng/mL RANKL): (1) no MLO-Y4 CM and no TNF-α (RANKL only; no TNF source); (2) TNF-α added directly to osteoclast cultures (TNF-α, no MLO-Y4); (3) Unstim CM added at 10% (v/v); (4) TNF-stim CM added at 10% (v/v); and (5) TNF-stim CM pre-incubated with a neutralizing anti-OPG antibody (AF459, R&D Systems) prior to addition to osteoclast cultures.

    Techniques: Expressing, Marker, Western Blot, Control, Enzyme-linked Immunosorbent Assay

    TNF-α-induced changes in Wnt/β-catenin-related transcripts and activation of the p38-MAPK-CREB signaling pathway in osteocytes. (A) Dot plots showing relative mRNA levels of Ctnnb1 (β-catenin), Lef1 , and Axin2 in MLO-Y4 cells treated with or without TNF-α ( n = 3). (B) Representative immunoblotting images showing phosphorylated p38 MAPK (p-p38), total p38, phosphorylated CREB (p-CREB), total CREB, phosphorylated JNK (p-JNK), total JNK, phosphorylated ERK (p-ERK), total ERK, and β-actin in MLO-Y4 cells following TNF-α treatment. Data in (A) are shown as individual values with the mean ± SD and were analyzed by the two-sided Student’s t -test. (C) Representative immunoblot of OPG in TNF-α-stimulated MLO-Y4 cells treated with a p38 inhibitor or a CREB inhibitor. Cells were stimulated with TNF-α in the presence or absence of SB203580 (p38 inhibitor) or 666-15 (CREB inhibitor), and total cell lysates were subjected to immunoblotting for OPG. β-actin serves as the loading control. Numeric values shown beneath each band represent the relative expression levels of OPG/β-actin for the corresponding lane. (D) ChIP-PCR demonstrating enrichment of the OPG promoter in anti-CREB immunoprecipitates from MLO-Y4 cells with or without TNF-α stimulation, with densitometric quantification of the ChIP-PCR bands; input DNA served as the internal control, normal IgG as the negative control, and anti-histone H3 as the positive control.

    Journal: JBMR Plus

    Article Title: Osteocytes regulate osteoprotegerin expression via the p38-MAPK-CREB pathway in rheumatoid arthritis

    doi: 10.1093/jbmrpl/ziag023

    Figure Lengend Snippet: TNF-α-induced changes in Wnt/β-catenin-related transcripts and activation of the p38-MAPK-CREB signaling pathway in osteocytes. (A) Dot plots showing relative mRNA levels of Ctnnb1 (β-catenin), Lef1 , and Axin2 in MLO-Y4 cells treated with or without TNF-α ( n = 3). (B) Representative immunoblotting images showing phosphorylated p38 MAPK (p-p38), total p38, phosphorylated CREB (p-CREB), total CREB, phosphorylated JNK (p-JNK), total JNK, phosphorylated ERK (p-ERK), total ERK, and β-actin in MLO-Y4 cells following TNF-α treatment. Data in (A) are shown as individual values with the mean ± SD and were analyzed by the two-sided Student’s t -test. (C) Representative immunoblot of OPG in TNF-α-stimulated MLO-Y4 cells treated with a p38 inhibitor or a CREB inhibitor. Cells were stimulated with TNF-α in the presence or absence of SB203580 (p38 inhibitor) or 666-15 (CREB inhibitor), and total cell lysates were subjected to immunoblotting for OPG. β-actin serves as the loading control. Numeric values shown beneath each band represent the relative expression levels of OPG/β-actin for the corresponding lane. (D) ChIP-PCR demonstrating enrichment of the OPG promoter in anti-CREB immunoprecipitates from MLO-Y4 cells with or without TNF-α stimulation, with densitometric quantification of the ChIP-PCR bands; input DNA served as the internal control, normal IgG as the negative control, and anti-histone H3 as the positive control.

    Article Snippet: For osteoclast differentiation assays, the following 5 conditions were compared (all containing 100 ng/mL RANKL): (1) no MLO-Y4 CM and no TNF-α (RANKL only; no TNF source); (2) TNF-α added directly to osteoclast cultures (TNF-α, no MLO-Y4); (3) Unstim CM added at 10% (v/v); (4) TNF-stim CM added at 10% (v/v); and (5) TNF-stim CM pre-incubated with a neutralizing anti-OPG antibody (AF459, R&D Systems) prior to addition to osteoclast cultures.

    Techniques: Activation Assay, Western Blot, Control, Expressing, Negative Control, Positive Control

    TNF-α-stimulated osteocyte-conditioned medium (CM) suppresses osteoclast differentiation partially via OPG. (A) Representative TRAP staining of osteoclasts generated under 5 conditions: (1) RANKL alone without any TNF-α source or osteocyte-CM (MLO-Y4−, TNF-α−); (2) direct TNF-α treatment in the absence of MLO-Y4 conditioned medium (MLO-Y4−, TNF-α+); (3) conditioned medium (CM) from unstimulated MLO-Y4 cells (MLO-Y4+, TNF-α−); (4) CM from TNF-α-stimulated MLO-Y4 cells collected after PBS wash and medium replacement (MLO-Y4+, TNF-α+); and (5) TNF-α-stimulated MLO-Y4 CM pre-incubated with a neutralizing anti-OPG antibody (AF459). Scale bars are 500 μm for low magnification and 200 μm for high magnification. (B) Dot plots of the percentage of spreading TRAP-positive osteoclasts for the conditions shown in (A) ( n = 3). (C) Quantitative RT-PCR analysis of Acp5 mRNA expression in osteoclast cultures under the conditions shown in (A). Acp5 expression levels were normalized to the reference gene ( n = 3). Data in (B and C) are individual values with mean ± SD; ** p < .01, **** p < .0001; ns indicates not significant by the one-way ANOVA with Tukey’s post-hoc test.

    Journal: JBMR Plus

    Article Title: Osteocytes regulate osteoprotegerin expression via the p38-MAPK-CREB pathway in rheumatoid arthritis

    doi: 10.1093/jbmrpl/ziag023

    Figure Lengend Snippet: TNF-α-stimulated osteocyte-conditioned medium (CM) suppresses osteoclast differentiation partially via OPG. (A) Representative TRAP staining of osteoclasts generated under 5 conditions: (1) RANKL alone without any TNF-α source or osteocyte-CM (MLO-Y4−, TNF-α−); (2) direct TNF-α treatment in the absence of MLO-Y4 conditioned medium (MLO-Y4−, TNF-α+); (3) conditioned medium (CM) from unstimulated MLO-Y4 cells (MLO-Y4+, TNF-α−); (4) CM from TNF-α-stimulated MLO-Y4 cells collected after PBS wash and medium replacement (MLO-Y4+, TNF-α+); and (5) TNF-α-stimulated MLO-Y4 CM pre-incubated with a neutralizing anti-OPG antibody (AF459). Scale bars are 500 μm for low magnification and 200 μm for high magnification. (B) Dot plots of the percentage of spreading TRAP-positive osteoclasts for the conditions shown in (A) ( n = 3). (C) Quantitative RT-PCR analysis of Acp5 mRNA expression in osteoclast cultures under the conditions shown in (A). Acp5 expression levels were normalized to the reference gene ( n = 3). Data in (B and C) are individual values with mean ± SD; ** p < .01, **** p < .0001; ns indicates not significant by the one-way ANOVA with Tukey’s post-hoc test.

    Article Snippet: For osteoclast differentiation assays, the following 5 conditions were compared (all containing 100 ng/mL RANKL): (1) no MLO-Y4 CM and no TNF-α (RANKL only; no TNF source); (2) TNF-α added directly to osteoclast cultures (TNF-α, no MLO-Y4); (3) Unstim CM added at 10% (v/v); (4) TNF-stim CM added at 10% (v/v); and (5) TNF-stim CM pre-incubated with a neutralizing anti-OPG antibody (AF459, R&D Systems) prior to addition to osteoclast cultures.

    Techniques: Staining, Generated, Incubation, Quantitative RT-PCR, Expressing

    CIHH downregulates RANKL expression and increases the OPG/RANKL ratio in delayed replanted teeth. A Immunohistochemistry staining showing OPG expression in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. Scale bar: 100 μm. B Immunohistochemistry staining showing RANKL expression in the root and periapical tissue of the NN and CIHH groups. Scale bar: 100 μm. C - D Representative Western blot bands ( C ) and quantitative analysis ( D ) showing OPG and RANKL protein expressions in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. D dentin; P: periodontal ligament; B: bone

    Journal: BMC Oral Health

    Article Title: Chronic intermittent hypobaric hypoxia attenuates root resorption following delayed tooth replantation by upregulating OPG/RANKL signaling pathway

    doi: 10.1186/s12903-026-08135-7

    Figure Lengend Snippet: CIHH downregulates RANKL expression and increases the OPG/RANKL ratio in delayed replanted teeth. A Immunohistochemistry staining showing OPG expression in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. Scale bar: 100 μm. B Immunohistochemistry staining showing RANKL expression in the root and periapical tissue of the NN and CIHH groups. Scale bar: 100 μm. C - D Representative Western blot bands ( C ) and quantitative analysis ( D ) showing OPG and RANKL protein expressions in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. D dentin; P: periodontal ligament; B: bone

    Article Snippet: Membranes were blocked with 5% skim milk and incubated with a mouse anti-OPG primary antibody (1:1000, Huabio, China) or a rabbit anti-RANKL primary antibody (1:1000, Huabio, China) overnight at 4 °C.

    Techniques: Expressing, Immunohistochemistry, Staining, Western Blot

    CIHH downregulates RANKL expression and increases the OPG/RANKL ratio in delayed replanted teeth. A Immunohistochemistry staining showing OPG expression in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. Scale bar: 100 μm. B Immunohistochemistry staining showing RANKL expression in the root and periapical tissue of the NN and CIHH groups. Scale bar: 100 μm. C - D Representative Western blot bands ( C ) and quantitative analysis ( D ) showing OPG and RANKL protein expressions in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. D dentin; P: periodontal ligament; B: bone

    Journal: BMC Oral Health

    Article Title: Chronic intermittent hypobaric hypoxia attenuates root resorption following delayed tooth replantation by upregulating OPG/RANKL signaling pathway

    doi: 10.1186/s12903-026-08135-7

    Figure Lengend Snippet: CIHH downregulates RANKL expression and increases the OPG/RANKL ratio in delayed replanted teeth. A Immunohistochemistry staining showing OPG expression in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. Scale bar: 100 μm. B Immunohistochemistry staining showing RANKL expression in the root and periapical tissue of the NN and CIHH groups. Scale bar: 100 μm. C - D Representative Western blot bands ( C ) and quantitative analysis ( D ) showing OPG and RANKL protein expressions in the root and periapical tissue of NN and CIHH groups of delayed replanted teeth. D dentin; P: periodontal ligament; B: bone

    Article Snippet: The sections were then incubated overnight at 4 °C with primary antibodies: a mouse anti-OPG antibody (1:1000, Huabio, China) or a rabbit anti-RANKL antibody (1:1000, Huabio, China).

    Techniques: Expressing, Immunohistochemistry, Staining, Western Blot

    Comparison of mRNA expression levels of TLR4, RANK, RANKL, and OPG in lung tissues of mice in each group. The mRNA levels were detected with real‐time quantitative PCR. (A) Level of RANKL mRNA. (B) Level of OPG mRNA. (C) Level of RANK mRNA. (D) Level of TLR4 mRNA. *** p < 0.001, **** p < 0.0001.

    Journal: Immunity, Inflammation and Disease

    Article Title: RANKL Attenuates Sepsis‐Associated Acute Lung Injury Through the OPG/RANKL/RANK/TLR4 Pathway

    doi: 10.1002/iid3.70356

    Figure Lengend Snippet: Comparison of mRNA expression levels of TLR4, RANK, RANKL, and OPG in lung tissues of mice in each group. The mRNA levels were detected with real‐time quantitative PCR. (A) Level of RANKL mRNA. (B) Level of OPG mRNA. (C) Level of RANK mRNA. (D) Level of TLR4 mRNA. *** p < 0.001, **** p < 0.0001.

    Article Snippet: After that, the pre‐diluted primary antibodies against OPG (cat# DF6824; Affinity Bioscience), RANKL (cat# 23408‐1‐AP; Proteintech Group Inc.), RANK (cat# ab222215; Abcam), TLR4 (cat# 19811‐1‐AP; Proteintech Group Inc.), and β‐actin (cat# TDY051; Tiandeyue Biotechnology Co. Ltd) were added and probed overnight at 4°C.

    Techniques: Comparison, Expressing, Real-time Polymerase Chain Reaction

    Comparison of protein expression levels of TLR4, RANK, RANKL, and OPG in lung tissues of mice in each group. The protein levels were detected with Western blot analysis. (A) Representative Western blot results. (B) The relative protein level of RANKL. (C) The relative protein level of OPG. (D) The relative protein level of RANK. (E) The relative protein level of TLR4. * p < 0.05, **** p < 0.0001.

    Journal: Immunity, Inflammation and Disease

    Article Title: RANKL Attenuates Sepsis‐Associated Acute Lung Injury Through the OPG/RANKL/RANK/TLR4 Pathway

    doi: 10.1002/iid3.70356

    Figure Lengend Snippet: Comparison of protein expression levels of TLR4, RANK, RANKL, and OPG in lung tissues of mice in each group. The protein levels were detected with Western blot analysis. (A) Representative Western blot results. (B) The relative protein level of RANKL. (C) The relative protein level of OPG. (D) The relative protein level of RANK. (E) The relative protein level of TLR4. * p < 0.05, **** p < 0.0001.

    Article Snippet: After that, the pre‐diluted primary antibodies against OPG (cat# DF6824; Affinity Bioscience), RANKL (cat# 23408‐1‐AP; Proteintech Group Inc.), RANK (cat# ab222215; Abcam), TLR4 (cat# 19811‐1‐AP; Proteintech Group Inc.), and β‐actin (cat# TDY051; Tiandeyue Biotechnology Co. Ltd) were added and probed overnight at 4°C.

    Techniques: Comparison, Expressing, Western Blot